A detailed history of Simplex Trading, LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 8,600 shares of CLDX stock, worth $282,596. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,600
Previous 24,101 64.32%
Holding current value
$282,596
Previous $1.01 Million 68.55%
% of portfolio
0.01%
Previous 0.03%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$32.76 - $42.56 $507,812 - $659,722
-15,501 Reduced 64.32%
8,600 $318,000
Q1 2024

Apr 25, 2024

BUY
$35.22 - $51.88 $848,837 - $1.25 Million
24,101 New
24,101 $1.01 Million
Q2 2023

Aug 04, 2023

BUY
$30.29 - $38.28 $14,872 - $18,795
491 New
491 $16,000
Q4 2022

Feb 02, 2023

BUY
$27.78 - $45.38 $88,507 - $144,580
3,186 Added 35.73%
12,102 $539,000
Q3 2022

Nov 04, 2022

SELL
$22.7 - $37.57 $173,201 - $286,659
-7,630 Reduced 46.11%
8,916 $250,000
Q2 2022

Aug 03, 2022

BUY
$20.5 - $37.33 $88,027 - $160,295
4,294 Added 35.05%
16,546 $446,000
Q1 2022

May 02, 2022

SELL
$27.64 - $39.32 $20,398 - $29,018
-738 Reduced 5.68%
12,252 $417,000
Q4 2021

Feb 23, 2022

SELL
$35.68 - $56.27 $853,501 - $1.35 Million
-23,921 Reduced 64.81%
12,990 $501,000
Q3 2021

Oct 28, 2021

SELL
$28.95 - $55.99 $5,790 - $11,198
-200 Reduced 0.54%
36,911 $1.27 Million
Q2 2021

Aug 12, 2021

BUY
$20.71 - $35.37 $715,841 - $1.22 Million
34,565 Added 1357.62%
37,111 $1.24 Million
Q1 2021

Apr 26, 2021

SELL
$16.19 - $29.91 $414,431 - $765,636
-25,598 Reduced 90.95%
2,546 $52,000
Q4 2020

Feb 02, 2021

BUY
$14.99 - $22.75 $166,119 - $252,115
11,082 Added 64.95%
28,144 $493,000
Q3 2020

Oct 14, 2020

SELL
$9.65 - $15.19 $439,364 - $691,600
-45,530 Reduced 72.74%
17,062 $253,000
Q2 2020

Jul 13, 2020

BUY
$1.61 - $13.41 $100,773 - $839,358
62,592 New
62,592 $813,000
Q1 2020

Apr 29, 2020

SELL
$1.55 - $3.07 $21,242 - $42,074
-13,705 Closed
0 $0
Q4 2019

Feb 05, 2020

BUY
$2.11 - $2.8 $20,091 - $26,661
9,522 Added 227.64%
13,705 $30,000
Q3 2019

Oct 15, 2019

SELL
$2.05 - $2.75 $3,243 - $4,350
-1,582 Reduced 27.44%
4,183 $8,000
Q2 2019

Jul 26, 2019

BUY
$2.43 - $5.09 $11,996 - $25,129
4,937 Added 596.26%
5,765 $15,000
Q1 2019

Apr 18, 2019

BUY
$3.45 - $10.35 $2,856 - $8,569
828 New
828 $0

Others Institutions Holding CLDX

About Celldex Therapeutics, Inc.


  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.54B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.